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Abstract
Rationale The involvement of somatostatin (SST) and its re-
ceptors in the pathophysiology of depression and stress has
been evidenced by numerous studies.
Objectives The purpose of the present study was to find
whether chronic mild stress (CMS), an animal model of de-
pression, affects the SST receptors in the rat brain and pitui-
tary, as well as the level of SST in plasma.
Methods In CMS model, rats were subjected to 2 weeks of
stress and behaviorally characterized using the sucrose con-
sumption test into differently reacting groups based on their
response to stress, i.e., stress-reactive (anhedonic), stress-non-
reactive (resilient), and invert-reactive rats (characterized by
excessive sucrose intake). We measured specific binding of
[125I]Tyr3-Octreotide, expression of mRNA encoding sst2R
receptors in the rat brains, expression of SST and its receptors
in rat pituitary, and the level of SST in the plasma.
Results The obtained results show decreases in binding of
[125I]Tyr3-Octreotide in most of rat brain regions upon CMS
and no significant differences between three stressed groups
of animals, except for significant up-regulation of sst2 recep-
tor in medial habenula (MHb) in the stress-reactive group. In
the same group of animals, significant increase in plasma SST
level was observed.
Conclusions There are two particularly sensitive sites
distinguishing the response to stress in CMS model. In the
brain, it is MHb, while on the periphery this predictor is SST
level in plasma. These changes may broaden an understanding
of the mechanisms involved in the stress response and point to
the intriguing role of MHb.
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Introduction
Major depressive disorder (MDD) is a psychiatric illnes which
touches about 5 % of the population. Despite numerous stud-
ies, the biochemical substrates of this disease (and thus new
pharmacological treatment) are still not fully understood.
Apart from classical neurotransmitters, some neuropeptides
are also altered in certain brain regions in MDD. One of them
is somatostatin (SST), widely distributed within the central
nervous system (CNS), acting both as neurotransmitter and
as neuromodulator (Engin and Treit 2009). Somatostatin
binds with high affinity to five somatostatin receptors, SST1,
SST2, SST3, SST4, and SST5, all belonging to the G-protein-
coupled receptor family. All SSTRs share common signaling
pathways such as the inhibition of adenylyl cyclase, activation
of phosphotyrosine phosphatase (PTP), and modulation of
mitogen-activated protein kinase (MAPK) via G-protein-
dependent mechanisms (Patel 1999). Somatostatin is co-
localized with gamma-aminobutyric acid (GABA) and is in-
volved in regulating multiple aspects of physiological and
behavioral stress responses (Engin et al. 2008; Lin and
Sibille 2013).
It has been widely accepted that stress is one of the main
causes of depression. Exposure to chronic stress is the leading
risk factor associated with mood symptoms (Keller et al.
2007). The involvement of SST in the pathophysiology of
depression and stress has been evidenced by numerous studies
on human and animal models. In patients with MDD, the
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decreased SST level in the cerebrospinal fluid (CSF) was ob-
served (Molchan et al. 1991; Frye et al. 2003). Low CSF SST
level was significantly correlated with cortisol in depressive
patients, suggesting the altered hypothalamic-pituitary-
adrenal (HPA) axis function described in some depressed pa-
tients (Molchan et al. 1993; Holsboer 2001); however, the
correlation between SST levels in CSF and plasma is not
known. Intracerebral administration of SST to animals in-
duces anxiolytic and antidepressant-like effects in the behav-
ioral tests (Engin and Treit 2009). Moreover, the effects of
SST2R and/or SST3R receptor agonists in the elevated plus-
maze and forced swim tests were equivalent to effects of an-
xiolytic and antidepressant drugs, which indicates the poten-
tial role of these receptors subtypes in the antidepressant ac-
tions (Nilsson et al. 2012). Results obtained by Tripp et al.
suggested an impaired excitation/inhibition balance in MDD
potentially mediated by decreased GABA content; however,
of relevance to this issue might be the results obtained recent-
ly, indicating a down-regulation of the SST levels in the ante-
rior cingulate cortex, dorsolateral prefrontal cortex, and amyg-
dala of MDD patients (Tripp et al. 2011; Sibille et al. 2011;
Guilloux et al. 2012; Lin and Sibille 2015).
The purpose of the present study was to find whether
chronic mild stress (CMS), an animal model of depression,
alters the SST receptors in the rat brain and pituitary as well as
the level of SST in the plasma. CMS is realistic and one of the
best validated animal model of depression (Willner 2005;
Wiborg 2013). In this model, rats were subjected to 2 weeks
of daily stress and behaviorally characterized using the su-
crose consumption test into differently reacting groups based
on their response to stress, i.e., anhedonic (stress-reactive,
stress-R), stress-resilient (stress-non-reactive, stress-NR), and
invert reactive rats (characterized by excessive sucrose intake,
stress-IR). The occurrence of resistance (or rather resilience)
or susceptibility to stress in animals subjected to CMS has
recently gained the interest of researchers (Bergström et al.
2008; Taliaz et al. 2011; Delgado y Palacios et al. 2011;
Christensen et al. 2011; Żurawek et al. 2013; Faron-Górecka
et al. 2014; Kolasa et al. 2014; Czéh et al. 2015), but the
molecular signature underlying the observed differences in
the behavioral responses to stress still remains unresolved.
Since the previously obtained data suggested the role of SST
in stress and depression, we decided to measure specific bind-
ing of [125I]Tyr3-Octreotide. Octreotide is SST2 and SST5
receptors (SST2R and SST5R, respectively) selective
(Hannon et al. 2002; Siehler et al. 1998). Because the sst5R
mRNA is present at low levels in the adult rodents brain
(Hannon et al. 2002; Feuerbach et al. 2000), and the SST5R
is mainly expressed in rat pituitary (Shimon 2003), we can say
indirectly that brain receptor autoradiography using
[125I]Tyr3-Octreotide allowed to observe mainly SST2R bind-
ing. Additionally, the expression of mRNA encoding sst2R
receptors in the rat brains as well as expression of SST and
its receptors in rat pituitary and the level of SST in the plasma
of rats subjected to 2 weeks of CMS procedure were
examined.
To the best of our knowledge, this is the first time when the
correlation between stress and SST receptors in the brain sec-
tions was measured using this animal model of depression.
Other studies were rather concentrated on the effect of antide-
pressant drugs on the SST levels using the elevated plus-maze
and forced swim test (Pallis et al. 2009; Engin and Treit 2009)
than on the impact of chronic stress. However, there are recent
studies concerning the CMS model, but the authors focused
their observation only on the hippocampus: the results obtain-
ed by Schaalan and Nassar (2011) demonstrate a possible
antidepressant-like activity of octreotide in CMS due to its
antioxidant/anti-inflammatory aptitude in the hippocampus,
while Czéh et al. (2015) tried to determine which subset of
GABAergic neurons are susceptible to the effect of chronic
stress. They showed that chronic stress reduced by 15–25 %
SST-ergic neurons in the CA1-2-3 areas of the hippocampus.
We report here that 2 weeks of chronic unpredictable stress
significantly influenced the SST2R level in the various brain
structures as well as the SST in the rat plasma. Moreover, it
appears that one of the crucial structures involved in the re-
sponse to stress, however often neglected in research, is the
medial habenula nucleus (MHb).
Materials and methods
The experiments were carried out in accordance with
Bioethical Committee at the Institute of Pharmacology,
Polish Academy of Sciences, Krakow, Poland.
Animals
Male Wistar Han rats were purchased from Charles River,
Germany. Animals’ weight was close to 300 g when adapta-
tion for sucrose consumption was initiated and approximately
350 g at the start of stress procedure. Rats were brought to the
laboratory 1 month prior to the start of the behavioral and
biochemical experiments. Except when grouping was applied
as a stress parameter, they were singly housed in plastic cages
(40×25×15 cm) with food and water provided ad libitum,
except when food or/and water deprivation was applied as a
stress parameter. The standard 12-h light/dark cycle was only
changed in course of stress regime.
Behavioral testing
Before the stress experiments, the animals were first trained to
consume a tasty sucrose solution (1 %). The training proce-
dure lasted for 6 weeks and consisted of 1-h testing sessions
every week in which the sucrose solution was presented to the
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rats in their home cages after 14 h of food and water depriva-
tion. Sucrose intake was measured after each drinking test as
difference in bottle weight. Chronic mild stress experiments
were performed according to the method described previously
(Żurawek et al. 2015; Kolasa et al. 2014). Briefly, each week
of the stress regime consisted of the following: two periods of
food or water deprivation; two periods of 450 cage tilt; two
periods of intermittent illumination (lights on and off every
2 h); two periods of soiled cage (250 ml water in sawdust
bedding); two periods of paired housing; two periods of low
intensity stroboscopic illumination (150 flashes/min); and two
periods of no stress. All stressors were 10–14 h of duration
and were applied individually and continuously, day and
night. Animals were deprived of food and water for 14 h pre-
ceding each sucrose test, but otherwise food and water were
freely available in the home cage. Control animals were
remained undisturbed in a separate room with free access to
food and water, except for a period of overnight deprivation
for the sucrose consumption test. During the 2 weeks of stress,
the sucrose consumption test was performed once a week, as
described by Żurawek et al. (2015). The operational cutoff
point between the control and stress-reactive group was based
on arbitrary retrospective observations and was set at 7.5 g of
sucrose consumption. Anhedonic animals (stress-reactive,
stress-R) displayed decreased sucrose consumption to below
7.5 g when compared with the final baseline test. Animals
resilient to stress (stress-non-reactive, stress-NR) character-
ized increased sucrose intake to above 7.5 g. The stress invert
reactive (stress-IR) group was characterized by overstated lev-
el of sucrose intake over 13.5 g. As a results of the experi-
ments, following groups of animals were selected: control rats
(without stress procedure) and—as a result of 2 weeks of
CMS: stress reactive/(stress-R); stress non-reactive/(stress-
NR); stress invert reactive/(stress-IR). For biochemical stud-
ies, 10 animals were randomly selected within each group
(Fig. 1).
Somatostatin receptor autoradiography—binding of [125I]
Tyr3-Octreotide
The rats were sacrificed by decapitation 24 h after the last
sucrose test. The brains were rapidly removed and frozen
using a heptane–dry ice mixture. Coronal brain sections
(12 μm) were cut using a Jung CM 3000 cryostat microtome
(Leica, Germany). The slices were thaw mounted on gelatine-
covered microscope slides, air dried, and stored at −20 °C
until use. In order to compare obtained slices with The Rat
Brain Atlas (Paxinos and Watson 1998), the cresyl violet
staining was performed. Receptor autoradiography was car-
ried out as described by Ferone et al. (1999). As radioligand,
the Somatostatin-28, Tyr25,[125I]-Leu8, D-Trp22 (Perkin
Elmer, Germany) in 0.1 nM concentration was used.
Nonspecific binding was determined by 1 μM non labeled
rat somatostatin-14 (SST14, Prospec, Israel). Data were ana-
lyzed using one-way analysis of variance (ANOVA). A post
hoc Bonferroni test was performed to locate differences be-
tween group means. The criterion for statistically significant
differences for all experimental groups was set at p<0.05.
Data are expressed as percent changes in specific binding
compared with the control group (expressed as 100 %) using
the GraphPad Prism 5.0.
In situ hybridization
The rat brain sections were fixed for 10 min in cold 4 %
formaldehyde, briefly washed in PBS, and incubated for
10 min in an ice-cold acetic anhydride (0.25 %)–TEA
(0.1 M) solution. The fixed brain slices were dehydrated in a
graded series of alcohols and subjected to two 10-min incu-
bations in chloroform to remove lipids. The prepared tissue
slices were washed in ethanol and air dried. For in situ hybrid-
ization, the synthetic oligonucleotide complementary to
R a t t u s n o r v e g i c u s s s t 2 R r e c e p t o r
(CGCGTTGCTTGTCATGTCGTAGTATGGCTC
TGTCTGGTTG) was used. Oligonucleotide probes were la-
belled at the 3′ end with [35S]dATP (Hartmann Analytic,
Germany) using terminal transferase (Fermentas, Lithuania).
The probes were suspended to a final concentration of 1×106
disintegration per minute (dpm) per 50 μl of hybridization
buffer. The sections were hybridized with the labelled oligo-
nucleotide for 18 h at 37 °C in a humidified incubator. Each
slide was briefly washed twice in a 1× SSC solution at room
temperature after hybridization, followed by four washes
(15 min each) in 2× SSC with 50 % formamide at 42 °C and
one for 15-min wash at room temperature in 1× SSC. The
hybridized brain sections were rinsed with deionized water,
dehydrated in increasing concentrations of ethanol, and air
dried. Prepared tissue sections were placed into X-ray cas-
settes and exposed to film plates (Kodak) for 20 days at a
temperature of −20 °C. The developed autoradiograms were
analyzed, quantified, and normalized using Image Gauge soft-
ware (Fujifilm, Japan).
Gene expression of sst and its receptors in the pituitary
Using the qPCR method, we determined the mRNA levels of
the sst and its receptors (sst2R, and sst5R) in the pituitaries of
experimental animals from each group. The levels of the
expressed genes were measured using a relative quantitative
method (efficiency-corrected), with the peptidylprolyl isomer-
ase A (Ppia) and ribosomal protein L32 (Rpl32) genes used as
reference genes and the control group as a calibrator. RNA
was reverse-transcribed with random hexamers to cDNA
using a High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, USA). Real-time PCRs were performed
in a Chromo4 Real-Time Detector System (Bio-Rad
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Laboratories, Inc., USA) and Opticon Monitor Software v.3
(Bio-Rad, USA). The primer concentrations and annealing
temperatures were checked and optimized experimentally.
Real-time PCR amplification was performed in a total reaction
volume of 20 μl, consisting of 10 μl Fast SYBRGreenMaster
Mix (Applied Biosystems, USA), 0.5 μM forward primer,
0.5 μM reverse primer, and 5 μl cDNA template (ca. 5–
10 ng reverse-transcribed total RNA per well). The sequences
of the primers and the annealing temperatures for each target
are given in Table 1. The thermal cycling profile consisted of
an initial incubation at 95 °C for 10 s, followed by 40 cycles of
denaturation at 95 °C for 15 s, annealing at a primer-specific
temperature (Table 1) for 1 min, and ending with 1 cycle of
final elongation at 72 °C for 7 min. For the qPCR reactions,
cDNAwas obtained from eight individuals from each group.
The samples were run in duplicates, with no template controls
in each experiment. A melting curve analysis was performed
to confirm the amplification specificity of the PCR products.
The results were calculated using qbasePLUS 2.0 software
(Biogazelle) and ΔΔCt method (Hellemans et al. 2007).
Reference genes stability was determined by calculating their
M value (M) and their coefficient of variation on the normal-
ized relative quantities (CV). For selected reference genes, the
obtained average M=0.680 and CV=23.6 %, which are
values accepted for heterogeneous samples (Hellemans et al.
2007; Kolasa et al. 2014).
Peptide concentration in plasma
Upon decapitation, blood was collected into tubes containing
EDTA and the plasmawas then separated and stored at −80 °C
for further analyses. The concentrations of the SST in the
plasma were determined in duplicates by an enzyme-linked
immunosorbent assays (ELISA) using commercially available
kit for rat SST28 (Phoenix Pharmaceuticals, Germany). The
ELISA procedures were performed as described by the man-




In the final baseline test after 2 weeks of stress, the intake of
1 % sucrose solution was significantly lower in stress-reactive
(stress-R) group vs. unstressed group (control) (1.71±0.16 vs.
9.74±2.16; p<0.001). In the stress non-reactive animals
(stress-NR), sucrose intake was comparable to the control
group (11.31±1.08 vs. 9.74±2.16, respectively) in contrast
to stress invert reactive group (stress-IR), where sucrose intake
was significantly higher (15.62±0.71 vs. 9.74±2.16,




Stress Invert Reactive (SIR)
Stress Non Reactive (SNR)
Control
Fig. 1 The scheme of 2 weeks of CMS procedure. In the final baseline
test after 2 weeks of stress, sucrose intakes were significantly different
between the controls and the stressed animals (F(1,40)=21.11,
p<0.0001). The graph shows the differences in sucrose intake after
2 weeks of stress. The data represents mean±S.E.M., n=10 animals per
group. For statistical analysis, a one-way ANOVA test was used with a
Bonferroni post hoc test
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respectively; p<0.001). Figure 1 shows the sucrose intake of
the rats used for the biochemical experiments.
Binding of [125I]Tyr3-Octreotide in rat brains
The Somatostatin-28, Tyr25,[125I]-Leu8, D-Trp22 is SST ana-
log that served as pharmaceutical octreotide acetate, which has
a high affinity to SST2R and SST5R receptors (Patel 1999). In
the control and all stressed groups, the high density of SST
receptors using [125I]Tyr3-Octreotide binding in different
brain areas was observed (Fig. 2). Rather a decrease of
[125I]Tyr3-Octreotide binding in selected rat brain structures
of limbic system was detected after 2 weeks of CMS proce-
dure (Fig. 3), except for medial habenular nucleus (MHb),
where in stress reactive group (stress-R) statistically signifi-
cant increase of ligand binding was observed [F(3,33)=7.502,
p<0.001, post hoc test p<0.05 vs. control group]. On the other
hand, we observed statistically significant decrease of
[125I]Tyr3-Octreotide binding in this structure for stress invert
reactive group (stress-IR), p<0.01 vs. stress reactive group
(stress-R). In the cingulate cortex (Cg) in all stressed groups,
regardless of behavioral response, statistically significant de-
crease of [125I]Tyr3-Octreotide binding was observed [F(3,
39)=11.54, p<0.0001]; however, this observation is more sig-
nificant for stress-NR and stress-IR groups (p<0.001 vs. con-
trol group). Similarly to changes observed in the Cg, also in
lateral septum nucleus (LSV) [F(3,33)=12.86, p<0.0001],
nucleus accumbens core (NAc) [F(3,37)=10.25, p<0.0001],
caudate putamen (CPu) [F(3,37)=4.54, p<0.01], and
basolateral amygdaloid nucleus, anterior part (BLA) [F(3,
39)=13.50], statistically significant decrease of [125I]Tyr3-
Octreotide binding was observed. Interestingly, that decreased
[125I]Tyr3-Octreotide binding was also observed in the dorsal
endopiriform nucleus (DEn), primary somatosensory cortex
(s1tr), and substantia nigra (SN) but only in stress-NR and
stress-IR groups [F(3,39)=14.71, p<0.0001; F(3,35)=5.27,
p<0.01; F(3,37)=9.42, p<0.0001, respectively]. Moreover,
in the SN, the decreased of SST-28 binding was statistically
significant vs. stress-R group (p<0.01). In the medial amyg-
daloid nucleus posteroventral part (MePV) [F(3,35)=4.55,
p<0.01] and paraventricular hypothalamic nucleus, medial
parvicellular part (PaMP) [F(3,39)=2.77, p<0.05], the
decrease of [125I]Tyr3-Octreotide binding, but only in stress-
NR group, was observed. Interestingly, in the dentate gyrus
(DG) of the hippocampus, we did not observe any statistically
significant changes. In the CA1 field of the hippocampus, the
statistically significant decrease was observed only in stress
invert reactive (stress-IR, p<0.01 vs. control). Conversely, in
the medial preoptic nucleus (MPO) only in stress reactive
(stress-R) and stress resilient (stress-NR) groups, the decrease
of [125I]Tyr3-Octreotide binding was observed [F(3, 37)=
4.58, p<0.01].
Levels of mRNA encoding sst2R- in situ hybridization
The expression of mRNA encoding sst2R in rat brains after
2 weeks of CMS was observed in CA1 and CA2 fields of the
hippocampus, DG, BLA, and MHb. In the MHb in stress-NR
and stress-IR groups, the tendency to decrease in mRNA
encoding sst2R was observed; however, this result did not
reach statistical significance (Fig. 4). Conversely, in the field
CA2 of the hippocampus, the increased sst2R mRNA expres-
sion in stress-NR and stress-IR was observed (p<0.05 vs.
stress R group). Moreover, in anhedonic (stress-R) animals,
the statistically significant decrease of mRNA encoding sst2R
was detected [F(3,30)=0.008, p<0.05 vs. control group). In
the DG in stress-IR group, statistically significant increase of
mRNA encoding sst2R was observed [F(3,39)=0.0007,
p<0.01 vs. control, stress-R and stress-NR groups]. Only in
BLA the decrease of mRNA encoding sst2R was observed in
all stressed groups. This effect was statistically significant as
compared to unstressed control group [F(3,25)=0.001,
p<0.05].
Gene expression in pituitary—RT-PCR
Using the qPCR method, we determined the mRNA levels of
the sst and its receptors (sst2R and sst5R) in the pituitaries of
experimental animals from each group. The levels of the
expressed genes were measured using a relative quantitative
method (efficiency-corrected), with the Ppia and Rpl32 genes
used as reference genes and Bthe control group^ (mix of
cDNA from all studied animals) as a calibrator. Because of
technical reasons—plates for RT-PCR include 96 wells—we
Table 1 Primers used for qPCR amplifications and annealing temperatures used for each pairs of primers
Accession no. Symbol Forward primer (5′-3′) Reverse primer (5′-3′) Tann [°C]
NM_019348 Sst2R GCCATGGAGTTGACCTCTG CATCTGCGATGGCCAGGTT 60
NM_012882 Sst5R ATGGAGCCCCTCTCTCTGG CGTCAGCCACGGCCAGGTT 63
NM_012659 SST TTCTGCAGAAGTCTCTGGCG ACAGGATGTGAATGTCTTCC 60
NM_013226 Rpl32a GTGAAGCCCAAGATCGTC GAACACAAAACAGGCACAC 60
NM_017101 Ppiaa TGACTTCACACGCCATAAT AGATGCCAGGACCTGTATGC 60
a Reference genes used for normalization
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used eight samples per group to diminish inter run variations
(8 samples per group × gene of interest+2 reference genes × 4
groups). According to the results of a one-way ANOVA, there
were significant differences in the expression of the sst5R
[F(3,31)=10.69, p<0.0001]. We observed significant de-
creases in sst5R expression in all stressed groups as compared
to the unstressed control. No changes were observed in the
expression of mRNA of sst and the sst2R (Table 2).
SST plasma level
In the plasma, the level of SST was increased significantly in
stress-R group after 2 weeks of CMS procedure (p<0.05 vs.
control group). Interestingly, in other stressed groups (NR and
IR), the decreased SST level was observed as compared to
stress-R group (p<0.05) (Fig. 5).
Discussion
Chronic mild stress procedure
Full procedure of CMS (7 weeks of stress) is usually applied
in research concerning the mechanisms of action of antide-
pressant drugs (Żurawek et al. 2015; Faron-Górecka et al.
2014); however, the symptoms of anhedonia can be observed
after a shorter time of stress, as shown both in this study and
by others (Kolasa et al. 2014; Luo et al. 2014; Luoni et al.
2014). Two weeks of stress led to the development of anhe-
donia manifested in stress-susceptible group of rats by the
decreased sucrose consumption (stress-reactive, stress-R).
Additionally, the group of animals not exhibiting any signs
of anhedonia despite being stressed (stress non-reactive,
stress-NR) and the group characterized by the increased su-
crose consumption (stress invert-reactive group, stress-IR)
were observed. Interestingly, despite the fact that the behav-
ioral responses of stress-NR and stress-IR groups were differ-
ent as shown by sucrose consumption, the molecular changes
in these two groups were similar in present studies, although
the results concerning the stress-IR group did not always reach
statistical significance but they represent very similar trend as
in stress-NR group. Similar correlation has been observed in
our previous studies, where we have shown surprising simi-
larity in gene expression and plasma ACTH levels in these
two groups (Kolasa et al. 2014). These results might indicate
parallelism underlying different ways to cope with stress con-
ditions. Comparison of these two groups (stress-NR and
stress-IR) showed that excessive intake of sucrose can be a
compensation of anxiety state. Stress-IR group is also very
interesting in the context of the phenomenon of the excessive
eating under stress. The emotional eating under the influence
of stress often leads to overeating and obesity (Singh 2014).
Similar data have been already described by Dallman et al.
(2003), who have shown that intake of palatable rewarding
food reduced signs of stress, thereby showing the potential of
Bcomfort eating^ in stress relief.
Impact of stress on the SST2R in rat brain
The results obtained using [125I]Tyr3-Octreotide suggest the
potential role of SST2R and SST5R in stress-related behav-
iors. Octreotide is SST2R and SST5R selective (Hannon et al.
2002; Siehler et al. 1998). Because the sst5RmRNA is present
Fig. 2 Representative autoradiograms of binding [125I]SST-28 in rat
brains after 2 weeks of CMS procedure. C—control group, SR—stress-
reactive group, SNR—stress non-reactive group, SIR—stress invert-
reactive group, NS—non specific binding obtained using 1 μM SST14
non labeled rat somatostatin-14. Brain structures were selected using the
Rat Brain Atlas Paxinos and Watson 1998
Fig. 3 The percentage of specific binding of [125I]Tyr3-Octreotide in
selected rat brain structures after 2 weeks of CMS procedure. The data
represent mean±S.E.M., n=10 animals per group. For statistical analysis,
a one-way ANOVA test was used with a Bonferroni post hoc test.
Asterisks indicate statistical significance vs. control group; *p<0.05,
**p<0.01, ***p<0.001; #p<0.01 statistical significance vs. stress
reactive group (stress R)
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at low levels in the adult rodents brain (Hannon et al. 2002;
Feuerbach et al. 2000), and the SST5R is mainly expressed in
rat pituitary (Shimon 2003), we can say indirectly that brain
receptor autoradiography using [125I]Tyr3-Octreotide allowed
to observe mainly SST2R binding. Such conclusion is also
justified by studies using SST2R knockout mice, where the
binding of this radioligand was not detected (Hannon et al.
2002). Our observations remain in agreement with available
data, indicating the involvement of SST2R in anxiolytic and
antidepressant actions. Infusion of a selective SST2R agonist
reduced anxiety-like behavior in rats and also antidepressant-
like effects were observed (Engin and Treit 2009). Using
knockout mice, it has been shown that SST2R KO exposed
to stress display a behavioral profile that is consistent with
increased anxiety (Viollet et al. 2000). In our study, we ob-
served, in many structures involved in the stress response,
e.g., Cg or BLA, reduced SST2R binding in the groups of rats
subjected to the stress procedures. The observed decrease of
SST2R binding in BLA and LSV in all stressed groups might
result as a response to the increased release of SST, since other
studies reported the anxiolytic activity of SST in the amygdala
and lateral septum. Noteworthy, the decrease of SST2R recep-
tors binding has been observed in the SN in two stressed
groups: stress-NR and stress-IR. Interestingly, we did not ob-
serve down-regulation of SST2R in stress-R group in this
brain region, which may reflect the lack of compensatory
mechanisms linked with neuroprotective effects of this neuro-
peptide. The decreased SST2R binding was observed in the
present studies also in the NAc in all stressed groups. It re-
mains in agreement with data obtained in studies indicating
that SST is released neuronally in this brain region, and there-
fore, it can influence the level of its receptors (Pallis et al.
2006).
One has to be aware that activation of brain SST2R potent-
ly stimulates food intake and, independently, drinking behav-
ior in rodents (Stengel et al. 2015). In our studies, prolonged
stress induced down-regulation of SST2R in most brain re-
gions studied—which may have influenced lower intake of
a b
Fig. 4 The level of mRNA encoding sst2R in rat brains after 2 weeks of
CMS. a Representative autoradiogram of in situ hybridization of sst2R
mRNA. b The level of sst2R mRNA in the rat brains. Data are expressed
as a mean of optical density (O.D.; means±S.E.M.; n=10 animals per
group). For statistical analysis, a one-way ANOVA test was used with a
Bonferroni post hoc test. *p<0.05, **p<0.01 vs. control group, $p<0.01
vs. stress R, #p<0.01 vs. stress non-reactive (stress NR) group
Table 2 Expression ofmRNA of Sst and its receptors in rat pituitaries. Data represents means±S.E.M.; n=8 animals per group. For statistical analysis,
a one-way ANOVA test was used with a Bonferroni post hoc test
Target Control Stress R Stress NR Stress IR
SST 1.169±0.309 1.513±0.345 0.931±0.147 1.167±0.080
Sst2R 1.081±0.190 1.068±0.209 1.042±0.133 1.336±0.221
Sst5R 3.440±0.736 1.803±0.294 * 0.720±0.101 ** 0.622±0.257 **
*p<0.05; **p<0.01, statistical significance vs. control group
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sucrose solution; however, this effect was also observed in the
stress-NR and stress-IR rats. Therefore, the stress itself seems
responsible for down-regulation of SST2R binding. On the
other hand, various stress conditions (i.e., exposure to noci-
ceptive stimuli, immobilization, handling) led to increase in
hypothalamic SST mRNA expression and peptide release
(Arancibia et al. 1984, 2000), which suggests that the en-
hanced release of SST under stress conditions might be re-
sponsible for down-regulation of SST2R, as shown in our
studies using [125I]Tyr3-Octreotide binding.
The most interesting results of our experiments is the bind-
ing of [125I]Tyr3-Octreotide in MHb. The habenula consists of
set of nuclei, which regulate the release of multiple
neuromodulators (Lecourtier and Kelly 2007). Most of studies
concerning mood or anxiety disorders focused on lateral
habenula nucleus (LHb) and/or did not distinguish the MHb
from the LHb. The role of LHb in psychiatric disorders such
as depression is well known (Hikosaka 2010; Aizawa et al.
2013; Christensen et al. 2013), while the role of MHb is
neglected (Viswanath et al. 2014). Some studies have sug-
gested that MHb plays a role in organizing or regulating many
behaviors, including sleep (Cui et al. 2014), circadian rhythm
(Zhao and Rusak 2005), pain (Shelton et al. 2012), fear re-
sponses (Agetsuma et al. 2010), and drug addiction
(Velasquez et al. 2014). In humans and rats, lesions of this
structure are correlated with schizophrenia (Lecourtier et al.
2004). Elevated activity in the MHb has also been linked with
depression. In rat model of learned helplessness, increased
activity in the MHb has been observed (Mirrione et al.
2014). Using zebrafish, it has been shown that MHb regulates
the expression of fear (Mathuru and Jesuthasan 2013). Other
data demonstrated that septo-habenular pathways regulate
anxiety-related and fear responses (Yamaguchi et al. 2013).
In the present studies, only in this structure we have observed
an up-regulation of SST2R in stress-R group, while in other
stressed groups no statistically significant changes (vs. un-
stressed control group) were observed. These results indicate
that MHb is stress-sensitive, which makes this brain region an
interesting site for stress resilience studies. Furthermore, the
regulation of SST2R on the MHb level can serve as good
potential site of action anxiolytic and antidepressant drugs.
Data obtained by in situ hybridization indicate that changes
in the binding of SST2R in anhedonic rats did not arise from
changes in expression of this receptor (lack of the changes in
sst2RmRNA expression). Also, other studies have shown that
ferret exposure did not alter levels of sst2R mRNAwithin the
MHb (Nanda et al. 2008).
As far as the hippocampus is concerned, despite the lack of
SST2R binding in field of CA2 of the hippocampus, the
changes of sst2R mRNA expression in this structure was ob-
served. This effect can be associated with remodeling of neu-
rons in the hippocampus. It has been shown recently that
chronic unpredictable stress reduces the number of
GABAergic interneurons (SST positive neurons) in the CA2
field of the hippocampus not only in anhedonic group but also
in the one resilient to stress (Czéh et al. 2015). Additionally,
only in stress-R group the decreased of sst2R mRNA expres-
sion was detected, in contrast to BLA, where in all stressed
groups the decrease of sst2R expression has been observed.
The changes in BLA are in opposite to the data obtained by
Nanda et al., since they observed, in ferret predator paradigm,
the increased sst2R mRNA expression (Nanda et al. 2008).
This discrepancy may be due to a variety of stress. The ferret
fear is rather severe and evolutionary conserved behavioral
response essential for survival, while in our CMS paradigm,
the mild stressors are introduced. Moreover, it has been shown
that in rats different stress procedures can disrupt fear extinc-
tion (Shansky 2015). Recently, it has been demonstrated that
amygdala activity was differentiated in high- and low-anxiety
rats following midazolam treatment, which indicates the indi-
vidual differences in local GABAergic activity (Skórzewska
et al. 2015).
Effect of stress on the pituitary
The pituitary, as a part of the hypothalamic-pituitary-adrenal
(HPA) axis, plays a significant role in the stress response. Our
previous studies have indicated that differential stress re-
sponse in rats subjected to 2 weeks of CMS was accompanied
by changes in CRH-family gene expression at the pituitary
level (Kolasa et al. 2014). It has been demonstrated that
sst2R and sst5R mRNA are expressed in the pituitary gland
in the rats (Zhang et al. 1999). Therefore, we decided to mea-
sure sst, sst2R, and sst5R gene expression in pituitaries of the
same rats after CMS procedure. In all stressed groups of ani-
mals, the decreased sst5R expression was observed, which
indicates the role of this type of receptor in stress responses,
although it did not differentiate the reaction to CMS, since the
Fig. 5 The plasma levels of SST in rats after 2 weeks of CMS procedure.
Data represents means±S.E.M.; n=10 animals per group. For statistical
analysis, a one-way ANOVA test was used with a Bonferroni post hoc
test. Asterisks **p<0.01 indicate statistical significance vs. control group;
#p<0.05 statistical significance vs. stress reactive group (stress R)
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alterations in sst5RmRNA expression were the same in stress-
R, stress-NR, as well as stress-IR rats. This receptor has been
shown to be involved in GH-secreting adenomas and
prolactinomas (Moore et al. 2005); however, its link with the
stress response in rat pituitary was not often suggested.
SST plasma level
Contrasting to the central effects, SSTactions in the periphery
are largely inhibitory (Stengel and Taché 2013). SST is re-
leased from nerve endings, neuroendocrine, inflammatory,
and immune cells in response to a wide range of inflammatory
mediators (Patel 1999). Our data indicated that changes of
SST level in the periphery are correlated with behavioral re-
sponse. In the stress-R group, the increased SST level was
observed in plasma. Interestingly, the present studies showed
that in other stressed groups (i.e., stress-NR and stress-IR),
SST levels were not different from the unstressed control
group. This observation indicates that the regulation of periph-
eral SST levels can be a predictor of sensitivity to stress.
Conclusion
The data obtained in the present studies confirm the involve-
ment of SST and its receptors (SST2R and SST5R) in re-
sponse to stress. It seems that there are two particularly sensi-
tive sites distinguishing the response to stress in CMS model.
In the brain, it is MHb and its sensitive reaction at the level of
SST2R, while on the periphery this predictor is SST level in
plasma. These changes may broaden the understanding of the
mechanisms involved in the stress response and point to the
intriguing role of MHb; however, further studies focusing on
this brain region are required.
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